You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Colon cancer BRAF

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, Stage IIB Colon Cancer AJCC v8 Trial (drug, biological, procedure,

Not yet recruiting
  • Colon Adenocarcinoma
  • +4 more
  • (no location specified)
Jan 24, 2023

Colorectal Cancer, BRAF V600E Mutation Positive Trial (Encorafenib Oral Capsule + Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • BRAF V600E Mutation Positive
  • Encorafenib Oral Capsule + Cetuximab
  • (no location specified)
Jan 30, 2023

Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-type Trial in Huzhou (Serplulimab Combined With FOLFIRI and

Recruiting
  • Unresectable Colon Cancer Peritoneal Metastases
  • PMMR/Ras/BRAF Wild-type
  • Serplulimab Combined With FOLFIRI and Bevacizumab
  • Huzhou, Zhejiang, China
    Changxing County People's Hospital
Feb 14, 2023

Colorectal Cancer, Colon Cancer, BRAF V600E Trial (Binimetinib)

Not yet recruiting
  • Colorectal Cancer
  • +4 more
  • (no location specified)
Aug 18, 2022

Metastatic Colon Adenocarcinoma, Metastatic Colorectal Adenocarcinoma, Metastatic Microsatellite Stable Colorectal Carcinoma

Terminated
  • Metastatic Colon Adenocarcinoma
  • +27 more
  • San Francisco, California
  • +1 more
Jan 5, 2023

Colonic Tumors Trial in Wuhan (neoadjuvant chemo)

Recruiting
  • Colonic Neoplasms
  • neoadjuvant chemotherapy
  • Wuhan, Hubei, China
    Tongji Hospital, Huazhong University of Science and Technology
Jul 19, 2022

Cancer of the Colon, Colon Cancer, Colon Tumors Trial in Chapel Hill (Cetuximab, Palbociclib)

Recruiting
  • Cancer of the Colon
  • +4 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Jan 25, 2022

Colon Cancer Trial in United States (Panitumumab, Nivolumab, Ipilimumab)

Active, not recruiting
Has Results
  • Colon Cancer
  • Tampa, Florida
  • +4 more
Nov 10, 2021

Stage IV Colorectal Cancer Positive for BRAF V600E Mutation, Colorectal Cancer, Colorectal Cancer Stage IV Trial in Chicago

Recruiting
  • Stage IV Colorectal Cancer Positive for BRAF V600E Mutation
  • +2 more
  • Hydroxychloroquine in Combination With Encorafenib and Cetuximab or Panitumumab
  • Chicago, Illinois
    Northwestern University
Nov 16, 2022

Anaplastic Thyroid Cancer Trial in Leiden (dabrafenib/trametinib)

Recruiting
  • Anaplastic Thyroid Cancer
  • Leiden, Zuid-Holland, Netherlands
    Ellen Kapiteijn
Oct 5, 2023

Advanced Colorectal Cancer Trial in Hangzhou (Cetuximab Dabrafenib Tislelizumab)

Not yet recruiting
  • Advanced Colorectal Cancer
  • Cetuximab Dabrafenib Tislelizumab
  • Hangzhou, Zhejing, China
    Zhejiang Cancer Institute & Hospital
Jul 19, 2023

Colorectal Cancer, Liver Metastases Trial (Cetuximab, Bevacizumab, mFOLFOX/FOLFIRI ( Standard Chemotherapy))

Not yet recruiting
  • Colorectal Cancer
  • Liver Metastases
  • (no location specified)
Aug 23, 2020

Metastatic Colon Adenocarcinoma, Metastatic Rectal Adenocarcinoma, Stage III Colon Cancer AJCC v8 Trial in United States

Recruiting
  • Metastatic Colon Adenocarcinoma
  • +7 more
  • Cetuximab
  • +2 more
  • Bloomington, Illinois
  • +70 more
Aug 6, 2022

Cancer Trial (Dabrafenib, Trametinib)

Not yet recruiting
  • Cancer
  • (no location specified)
May 25, 2023

Melanoma (Skin), Skin Cancer, Skin Melanoma Trial in Tampa (Vemurafenib, Cobimetinib)

Recruiting
  • Melanoma (Skin)
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Dec 30, 2022

NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • +32 more
  • (no location specified)
Mar 30, 2023

Colo-rectal Cancer Trial (biological, drug, procedure)

Not yet recruiting
  • Colo-rectal Cancer
  • Recombinant Human EGF-rP64K/Montanide ISA 51 Vaccine
  • +8 more
  • (no location specified)
Aug 28, 2023

Aspirin in Combination With Trametinib and Dabrafenib

Not yet recruiting
  • NSCLC
  • +4 more
  • Combind asprin with Trametinib and Dabrafenib
  • (no location specified)
Aug 4, 2023

BRAF NP_004324.2:p.V600E, BRAF V600K Mutation Present, Thyroid Gland Anaplastic Carcinoma Trial in Duarte, Columbus (Dabrafenib,

Recruiting
  • BRAF NP_004324.2:p.V600E
  • +2 more
  • Duarte, California
  • +1 more
Jan 19, 2023

NSCLC, BRAF V600 Mutation, MET Exon 14 Mutation Trial in Guangzhou (Dabrafenib + Trametinib, Capmatinib)

Not yet recruiting
  • NSCLC
  • +2 more
  • Guangzhou, Guangdong, China
    Cancer Center of Sun-Yat Sen University
Sep 19, 2023

Cancer Harboring BRAF Alterations Trial (FORE8394, Cobicistat)

Not yet recruiting
  • Cancer Harboring BRAF Alterations
  • (no location specified)
Aug 15, 2022

Colon Cancer Trial in Lexington (TVB-2640, Placebo)

Recruiting
  • Colon Cancer
  • Lexington, Kentucky
    University of Kentucky
Jan 18, 2023

Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Cetuximab + Envafolimab + mFOLFOXIRI
  • Cetuximab + mFOLFOX6/FOLFIRI
  • (no location specified)
Jul 24, 2023

Melanoma Trial in Boston (MCS110, Dabrafenib, Trametinib)

Active, not recruiting
  • Melanoma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 14, 2022

Clinical Significance of Marginal Acute Inflammation for Stage

Completed
  • Inflammation
  • Colon Cancer
  • MAI detection
  • (no location specified)
Nov 11, 2023